National Cancer Institute to Study Ivermectin as Potential Cancer Treatment
The National Cancer Institute (NCI) plans to conduct a study on the use of ivermectin to treat cancer, according to a top official. Ivermectin is an FDA-approved anti-parasitic medication commonly used to treat various infections caused by internal and external parasites, such as parasitic worms and head lice, though the drug rose in popularity—and scrutiny—during […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
American Medical Association Launches Its Own Vaccine Review Process
The American Medical Association (AMA), a medical trade advocacy association, is partnering with a vaccine research group to launch what it describes as an independent, “evidence-based review process” for respiratory vaccines for the next flu season—a role traditionally carried out by the U.S. Centers for Disease Control and Prevention (CDC).1 2 According to a prepared […]
AAP Issues Its Own Recommended Childhood Vaccine Schedule
The American Academy of Pediatrics (AAP) has released its own recommended childhood vaccine guidance, breaking with updated recommendations issued earlier this month by the U.S. Centers for Disease Control and Prevention (CDC).1 On Jan. 6, 2026, the CDC formally updated the U.S. childhood vaccination schedule, introducing changes as to how vaccines are categorized and recommended. […]
Novavax Signs Licensing Agreement With Pfizer for Vaccine Adjuvant Technology
Novavax, Inc. and Pfizer, Inc. have signed a licensing arrangement allowing Pfizer access to Novavax’s Matrix-M adjuvant technology to boost immune response to vaccines. The agreement will allow for use in vaccines targeting up to two infectious diseases.1 Novavax’s Matrix-M technology is an aluminum-free adjuvant designed to enhance the immune response in protein-based vaccines such […]
CDC Scientist and Whistleblower Promoted to Research Vaccine Adverse Childhood Experiences
A senior researcher at the U.S. Centers for Disease Control and Prevention (CDC) William Thompson, PhD, who previously came forward in 2014 as a whistleblower claiming that the agency omitted statistically significant data related to MMR (measles-mumps-rubella)vaccine risks, has been promoted to oversee federal research into adverse experiences in childhood affecting long-term health outcomes for […]